{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T22:38:24Z","timestamp":1765233504702,"version":"build-2065373602"},"reference-count":63,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.path.2023.01.002","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T07:49:07Z","timestamp":1679903347000},"page":"177-195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Immunoglobulin G4-Related Disease, Lymphadenopathy, and Lymphoma"],"prefix":"10.1016","volume":"16","author":[{"given":"Jacob R.","family":"Bledsoe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.path.2023.01.002_bib1","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"Deshpande","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2023.01.002_bib2","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1097\/PAS.0b013e3181f7266b","article-title":"IgG4-related disease: a cross-sectional study of 114 cases","volume":"34","author":"Zen","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.01.002_bib3","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/rheumatology\/kev203","article-title":"Clinical characteristics of immunoglobulin G4\u2013related disease: a prospective study of 118 Chinese patients","volume":"54","author":"Lin","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.path.2023.01.002_bib4","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1002\/art.39205","article-title":"IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients","volume":"67","author":"Wallace","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.path.2023.01.002_bib5","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jaci.2015.12.1330","article-title":"Clonal expansion of CD4(+) cytotoxic T lymphocytes in patients with IgG4-related disease","volume":"138","author":"Mattoo","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.path.2023.01.002_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/08916934.2017.1280029","article-title":"Clonally expanded cytotoxic CD4+ T cells and the pathogenesis of IgG4-related disease","volume":"50","author":"Mattoo","year":"2017","journal-title":"Autoimmunity"},{"key":"10.1016\/j.path.2023.01.002_bib7","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/s41584-020-0500-7","article-title":"IgG4-related disease: an update on pathophysiology and implications for clinical care","volume":"16","author":"Perugino","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.path.2023.01.002_bib8","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1002\/art.39209","article-title":"Number of circulating follicular helper 2 T cells correlates with IgG4 and interleukin-4 levels and plasmablast numbers in IgG4-related disease","volume":"67","author":"Akiyama","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.path.2023.01.002_bib9","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/rheumatology\/kex171","article-title":"Follicular helper T cells in the pathogenesis of IgG4-related disease","volume":"57","author":"Akiyama","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.path.2023.01.002_bib10","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.autrev.2016.12.008","article-title":"IgG4-related disease: evidence from six recent cohorts","volume":"16","author":"Mart\u00ednez-Valle","year":"2017","journal-title":"Autoimmu Rev"},{"key":"10.1016\/j.path.2023.01.002_bib11","doi-asserted-by":"crossref","first-page":"358371","DOI":"10.1155\/2012\/358371","article-title":"Prevalence of IgG4-related disease in Japan based on nationwide survey in 2009","volume":"2012","author":"Uchida","year":"2012","journal-title":"Int J Rheumatol"},{"key":"10.1016\/j.path.2023.01.002_bib12","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1186\/s12969-016-0079-3","article-title":"IgG4-related disease: a systematic review of this unrecognized disease in pediatrics","volume":"14","author":"Karim","year":"2016","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.path.2023.01.002_bib13","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00296-021-04885-5","article-title":"IgG4-related disease in pediatric patients: a single-center experience","volume":"42","author":"Akca","year":"2022","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.path.2023.01.002_bib14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","article-title":"Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011","volume":"22","author":"Umehara","year":"2012","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.path.2023.01.002_bib15","doi-asserted-by":"crossref","first-page":"20190448","DOI":"10.1259\/bjr.20190448","article-title":"Cross-sectional pictorial review of IgG4-related disease","volume":"92","author":"Kurowecki","year":"2019","journal-title":"Br J Radiology"},{"key":"10.1016\/j.path.2023.01.002_bib16","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/PAS.0000000000001579","article-title":"IgG4-related Lymphadenopathy","volume":"45","author":"Bledsoe","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.01.002_bib17","unstructured":"Cheuk W., Zen Y., Ferry J.A., et al., IgG4-related disease. In: WHO Classification of Tumours Editorial Board. Haematolymphoid tumours [Internet; beta version ahead of print.] Lyon (France): International Agency for Research on Cancer; 2022. (WHO classification of tumours series, 5th ed.; vol. 11). Available at: https:\/\/tumourclassification.iarc.who.int\/chapters\/63."},{"key":"10.1016\/j.path.2023.01.002_bib18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/annrheumdis-2013-204907","article-title":"The diagnostic utility of serum IgG4 concentrations in IgG4-related disease","volume":"74","author":"Carruthers","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.path.2023.01.002_bib19","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3324\/haematol.2018.205526","article-title":"IgG4-related disease: what a hematologist needs to know","volume":"104","author":"Chen","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.path.2023.01.002_bib20","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ajg.2016.40","article-title":"Elevated serum IgG4 levels in diagnosis, treatment response, organ involvement, and relapse in a prospective IgG4-related disease UK cohort","volume":"111","author":"Culver","year":"2016","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.path.2023.01.002_bib21","first-page":"602809","article-title":"Pathologies associated with serum IgG4 elevation","volume":"2012","author":"Ebbo","year":"2012","journal-title":"Int J Rheumatol"},{"key":"10.1016\/j.path.2023.01.002_bib22","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/his.13186","article-title":"Comparison of clinical and pathological features of lung lesions of systemic IgG4-related disease and idiopathic multicentric Castleman\u2019s disease","volume":"70","author":"Terasaki","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2023.01.002_bib23","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/modpathol.2013.159","article-title":"IgG4 plasma cell myeloma: new insights into the pathogenesis of IgG4-related disease","volume":"27","author":"Geyer","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2023.01.002_bib24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/AJCP\/AQX067","article-title":"Atypical IgG4+ plasmacytic proliferations and lymphomas: characterization of 11 cases","volume":"148","author":"Bledsoe","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.path.2023.01.002_bib25","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/modpathol.2010.206","article-title":"Marginal zone lymphomas involving meningeal dura: possible link to IgG4-related diseases","volume":"24","author":"Venkataraman","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2023.01.002_bib26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/all.12320","article-title":"Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease","volume":"69","author":"Della-Torre","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.path.2023.01.002_bib27","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1038\/modpathol.2013.106","article-title":"Primary cutaneous marginal zone lymphomas with plasmacytic differentiation show frequent IgG4 expression","volume":"26","author":"Brenner","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2023.01.002_bib28","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/his.13136","article-title":"IgG4-related disease-experience of 100 consecutive cases from a specialist centre","volume":"70","author":"Bateman","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2023.01.002_bib29","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/jcp.2010.085613","article-title":"Numerous IgG4-positive plasma cells are ubiquitous in diverse localised nonspecific chronic inflammatory conditions and need to be distinguished from IgG4-related systemic disorders","volume":"64","author":"Strehl","year":"2011","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.path.2023.01.002_bib30","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/his.12274","article-title":"A\u00a0subset of Rosai-Dorfman disease cases show increased IgG4-positive plasma cells: another red herring or a true association with IgG4-related disease?","volume":"64","author":"Menon","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2023.01.002_bib31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/1066896911420562","article-title":"Increased numbers of IgG4-positive plasma cells may rarely be seen in lymph nodes of patients without IgG4-related sclerosing disease","volume":"20","author":"Rollins-Raval","year":"2011","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.path.2023.01.002_bib32","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1136\/jcp.2010.082958","article-title":"Multicentric Castleman\u2019s disease with abundant IgG4-positive cells: a clinical and pathological analysis of six cases","volume":"63","author":"Sato","year":"2010","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.path.2023.01.002_bib33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3960\/jslrt.52.57","article-title":"Rheumatoid lymphadenopathy with abundant IgG4(+) plasma cells : a case mimicking IgG4-related disease","volume":"52","author":"Asano","year":"2012","journal-title":"J\u00a0Clin Exp Hematop"},{"key":"10.1016\/j.path.2023.01.002_bib34","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/PAS.0000000000001167","article-title":"Morphologic overlap between inflammatory myofibroblastic tumor and IgG4-related disease: lessons from next-generation sequencing","volume":"43","author":"Taylor","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.01.002_bib35","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1309\/AJCPX6VF6BGZVJGE","article-title":"Abundance of IgG4+ plasma cells in isolated reactive lymphadenopathy is no indication of IgG4-related disease","volume":"142","author":"Martinez","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.path.2023.01.002_bib36","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1053\/j.semdp.2012.07.001","article-title":"Lymphadenopathy of IgG4-related disease: an underdiagnosed and overdiagnosed entity","volume":"29","author":"Cheuk","year":"2012","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.path.2023.01.002_bib37","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/PAS.0b013e318157c068","article-title":"Lymphadenopathy of IgG4-related sclerosing disease","volume":"32","author":"Cheuk","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.01.002_bib38","doi-asserted-by":"crossref","first-page":"572539","DOI":"10.1155\/2012\/572539","article-title":"IgG4-Related Lymphadenopathy","volume":"2012","author":"Sato","year":"2012","journal-title":"Int J Rheumatol"},{"key":"10.1016\/j.path.2023.01.002_bib39","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/PAS.0000000000001076","article-title":"A\u00a0newly recognized histologic pattern of IgG4-related lymphadenopathy: expanding the morphologic spectrum","volume":"42","author":"Chen","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.01.002_bib40","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1440-1827.2010.02524.x","article-title":"IgG4-related disease: historical overview and pathology of hematological disorders","volume":"60","author":"Sato","year":"2010","journal-title":"Pathol Int"},{"key":"10.1016\/j.path.2023.01.002_bib41","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/modpathol.2012.54","article-title":"Association between IgG4-related disease and progressively transformed germinal centers of lymph nodes","volume":"25","author":"Sato","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2023.01.002_bib42","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/his.12658","article-title":"Lymph node granulomas in immunoglobulin G4-related disease","volume":"67","author":"Bateman","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2023.01.002_bib43","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/BOR.0b013e3283413011","article-title":"IgG4-associated sialadenitis","volume":"23","author":"Geyer","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.path.2023.01.002_bib44","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.mpdhp.2013.01.005","article-title":"IgG4-related lymphadenopathy and IgG4-related lymphoma: moving targets","volume":"19","author":"Ferry","year":"2013","journal-title":"Diagn Histopathol"},{"key":"10.1016\/j.path.2023.01.002_bib45","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/PAS.0b013e31816148ad","article-title":"Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacryoadenitis: a previously undescribed complication of IgG4-related sclerosing disease","volume":"32","author":"Cheuk","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.01.002_bib46","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00428-017-2286-9","article-title":"Lymphomas in IgG4-related disease: clinicopathologic features in a Western population","volume":"472","author":"Bledsoe","year":"2018","journal-title":"Virchows Arch"},{"key":"10.1016\/j.path.2023.01.002_bib47","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13075-021-02652-2","article-title":"The risk of malignancy in patients with IgG4-related disease: a systematic review and meta-analysis","volume":"24","author":"Yu","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.path.2023.01.002_bib48","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/MPA.0b013e31819d73ca","article-title":"Possible association between IgG4-associated systemic disease with or without autoimmune pancreatitis and non-Hodgkin lymphoma","volume":"38","author":"Takahashi","year":"2009","journal-title":"Pancreas"},{"key":"10.1016\/j.path.2023.01.002_bib49","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3109\/s10165-011-0520-x","article-title":"Risk of malignancies in IgG4-related disease","volume":"22","author":"Yamamoto","year":"2014","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.path.2023.01.002_bib50","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1136\/jcp.2010.082156","article-title":"Ocular adnexal marginal zone B cell lymphoma infiltrated by IgG4-positive plasma cells","volume":"63","author":"Kubota","year":"2010","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.path.2023.01.002_bib51","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/pin.12932","article-title":"Clinicopathological differential diagnosis of IgG4-related disease: A historical overview and a proposal of the criteria for excluding mimickers of IgG4-related disease","volume":"70","author":"Satou","year":"2020","journal-title":"Pathol Int"},{"key":"10.1016\/j.path.2023.01.002_bib52","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/PAS.0000000000000575","article-title":"Multicentric Castleman disease with tubulointerstitial nephritis mimicking IgG4-related disease: two case reports","volume":"40","author":"Zoshima","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.01.002_bib53","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/PAS.0000000000001617","article-title":"Rosai-Dorfman disease displays a unique monocyte-macrophage phenotype characterized by expression of OCT2","volume":"45","author":"Ravindran","year":"2021","journal-title":"Am J Surg Pathology"},{"key":"10.1016\/j.path.2023.01.002_bib54","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/bjh.16006","article-title":"Cyclin D1 expression and novel mutational findings in Rosai-Dorfman disease","volume":"186","author":"Baraban","year":"2019","journal-title":"Brit J Haematol"},{"key":"10.1016\/j.path.2023.01.002_bib55","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/PAS.0000000000000987","article-title":"Syphilis of the aerodigestive tract","volume":"42","author":"Tse","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.01.002_bib56","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/his.13965","article-title":"Increased IgG4-positive plasma cells in nodular-sclerosing Hodgkin lymphoma: a diagnostic pitfall","volume":"76","author":"Nowak","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2023.01.002_bib57","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1097\/PAS.0000000000000206","article-title":"Epstein-Barr virus\u2013infected cells in IgG4-related lymphadenopathy with comparison with extranodal IgG4-related disease","volume":"38","author":"Takeuchi","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.01.002_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ajcp\/aqab090","article-title":"How I diagnose angioimmunoblastic T-cell lymphoma","volume":"156","author":"Xie","year":"2021","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.path.2023.01.002_bib59","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.carpath.2012.02.001","article-title":"Dense IgG4 plasma cell infiltrates associated with chronic infectious aortitis: implications for the diagnosis of IgG4-related disease","volume":"21","author":"Siddiquee","year":"2012","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.path.2023.01.002_bib60","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s12105-016-0710-0","article-title":"Recurrent mastoiditis mimics IgG4 related disease: a potential diagnostic pitfall","volume":"10","author":"Deshpande","year":"2016","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.path.2023.01.002_bib61","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/his.14428","article-title":"A\u00a0comparative study of Kimura\u2019s disease and IgG4-related disease: similarities, differences and overlapping features","volume":"79","author":"Wang","year":"2021","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2023.01.002_bib62","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000335372","article-title":"IgG4-related skin disease, a mimic of angiolymphoid hyperplasia with eosinophilia","volume":"223","author":"Hamaguchi","year":"2012","journal-title":"Dermatology"},{"key":"10.1016\/j.path.2023.01.002_bib63","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1097\/PAS.0000000000000497","article-title":"IgG4-related orbital disease and its mimics in a Western population","volume":"39","author":"Ferry","year":"2015","journal-title":"Am J Surg Pathol"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918123000028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918123000028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:42:45Z","timestamp":1761748965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918123000028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1875918123000028"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2023.01.002","relation":{},"ISSN":["1875-9181"],"issn-type":[{"type":"print","value":"1875-9181"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunoglobulin G4-Related Disease, Lymphadenopathy, and Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2023.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}